Harvard Pilgrim Health Care
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Harvard Pilgrim Health Care sits in the top decile of US sponsors by registered trial count (#568 of 15,742 sponsors by registered trial count).
Harvard Pilgrim Health Care: 28 sponsored US clinical trials, 1 recruiting.
Harvard Pilgrim Health Care sponsors 28 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 25 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 1 Diabetes, with 2 trials.
Top-decile sponsor footprint
Harvard Pilgrim Health Care ranks in the top decile of sponsors by registered trial count (#568 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
25 of 25 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
28 total, page 1 of 1
InvesT1D: Promoting Adolescent Investment in Diabetes Care
NCT06384911
Predictive Analytics and Clinical Decision Support to Improve PrEP Prescribing
NCT06805877
Clinical Decision Support for PrEP
NCT05245201
Front-of-Package Nutrition Labels
NCT06516627
Eco-labels on Restaurant Menus
NCT06584539
INSPIRE Trial for Skin and Soft Tissue Infections
NCT05423756
INSPIRE Trial for Abdominal Infections
NCT05423743
Collaborative Care Coordination Program for Alzheimer's Disease and Related Dementias
NCT05281744
Asthma in Families Facing Out-of-pocket Requirements Due to COVID-19
NCT04613739
Promoting Adolescent Investment In Diabetes Care
NCT04516694
CLUSTER Trial for Outbreak Detection and Response
NCT04053075
The INSPIRE-ASP UTI Trial
NCT03697096
The INSPIRE-ASP PNA Trial
NCT03697070
Prepare - How to Reach Women of Reproductive Age With Obesity to Support Weight Loss Before Pregnancy?
NCT03663621
IMplementation of an RCT to imProve Treatment With Oral AntiCoagulanTs in Patients With Atrial Fibrillation
NCT03259373
Mupirocin-Iodophor ICU Decolonization Swap Out Trial
NCT03140423
Asthma in Families Facing Out-of-pocket Requirements With Deductibles
NCT03175536
Brigham and Women's Healthy Weight Study
NCT02709642
Health Coach Intervention Pilot Study
NCT03080064
CDC Prevention Epicenters Wake Up and Breathe Collaborative
NCT01583413
Healthy Habits, Happy Homes: An Intervention to Improve Household Routines for Obesity Prevention
NCT01565161
Study of Technology to Accelerate Research
NCT01537510
Trial of Fish Intake Advice in Pregnancy
NCT01126762
Understanding Fish Consumption Habits During Pregnancy
NCT01178398
Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs)
NCT00980980
Automated Telephone Outreach With Speech Recognition to Improve Diabetes Care: A Randomized Controlled Study
NCT00790530
Safety Study of GBS Following Menactra Meningococcal Vaccination
NCT00575653
RCT of Automated Telephone Outreach to Improve Colorectal Cancer Screening
NCT00792285
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Where Harvard Pilgrim Health Care enrollment is open (later-stage tilt)
1 recruiting of 28 indexed (4% open); 25 completed (89%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Type 1 Diabetes (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Harvard Pilgrim Health Care: open-pipeline peers nationwide
Peers matched on 28 registered trials and 4% open enrollment, not the therapeutic-area sidebar.
Harvard Pilgrim Health Care sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 28 trials (± recruiting share)
- Axsome Therapeutics · 28 trials · 21% recruiting
- Benaroya Research Institute · 28 trials · 14% recruiting
- CAMC Health System · 28 trials · 11% recruiting
- CTI BioPharma · 28 trials · 0% recruiting
Sponsors near 4% open enrollment (± trial volume)
- Bausch Health Americas · 4% recruiting · 168 trials
- Sumitomo Pharma America · 4% recruiting · 168 trials
- Bayer · 4% recruiting · 591 trials
- Teva Branded Pharmaceutical Products R&D · 4% recruiting · 167 trials
Related
What to do with this Harvard Pilgrim Health Care page
28 registered trials is a research-attention snapshot, not an endorsement of Harvard Pilgrim Health Care or any single study.
- 1 of Harvard Pilgrim Health Care's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 1 Diabetes is the condition Harvard Pilgrim Health Care studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 1 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Harvard Pilgrim Health Care pipeline card: 28 registered trials from official public datasets.Report a data error.